Search results
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 11 hours agoThe Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 9 hours agoMergers and acquisitions continue to be in the spotlight as pharma and biotech majors look to...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 11 hours agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids...
Digital Journal· 8 hours agoWith its cutting-edge technology and unwavering commitment to sustainability and quality, CB Therapeutics hopes to lead the charge in cannabinoid therapeutics. The company looks forward to collaborating ...
Crinetics Pharmaceuticals Inc (CRNX) Shares Rise Despite Market Challenges – News Heater
NewsHeater· 16 hours agoIs It Worth Investing in Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) Right Now? The 36-month beta value for CRNX is at 0.63.
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 2 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
Covaxin has excellent safety record, says Bharat Biotech
Investing.com· 18 hours agoCovaxin has excellent safety record, says Bharat Biotech
MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES
KOLR - KSFX Ozarks· 10 hours agoMyonex has completed the previously announced acquisition of CREAPHARM's pharmaceutical services business. This transaction combines capabilities and flexibility to serve ...
Duopharma Biotech Berhad Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 2 days agoThe company's shares are up 1.7% from a week ago. Risk Analysis It...
Newron's schizophrenia add-on improves symptoms, charging up case for phase 3 test
FierceBiotech· 2 days agoNewron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms...